Home » Justice Department » You are reading »

U.S. Renal Care to Pay $7.3 Million to Resolve False Claims Act Allegations

opencrim February 16, 2018 U.S. Renal Care to Pay $7.3 Million to Resolve False Claims Act Allegations2018-02-16T06:00:51+00:00 Justice Department

U.S. Renal Care to Pay $7.3 Million
to Resolve False Claims Act Allegations

U.S. Renal Care, headquartered in Plano, Texas, has agreed to pay $7.3 million to resolve allegations that Dialysis Corporation of America (DCA) violated the False Claims Act by submitting false claims to the Medicare program for more Epogen than was actually administered to dialysis patients at DCA facilities.

Go to Source